Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma
- 1 September 1993
- Vol. 42 (3), 250-257
- https://doi.org/10.1016/0090-4295(93)90612-e
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Immunotherapy for metastatic renal-cell carcinomaWorld Journal of Urology, 1991
- Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinomaUrology, 1991
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- Interferon therapy of metastatic renal cell cancerSeminars in Surgical Oncology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Spontaneous regression of metastatic renal cell carcinomaUrology, 1982
- Liver metastasesCurrent Problems in Surgery, 1981
- NEPHROGENIC RIDGE TUMORS AND THEIR SYNDROMESAnnals of the New York Academy of Sciences, 1974